{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:17:31Z","timestamp":1790756251936,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T00:00:00Z","timestamp":1447718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ebiom.2015.11.031","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T02:46:31Z","timestamp":1447901191000},"page":"1944-1956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["PP2AC Level Determines Differential Programming of p38-TSC-mTOR Signaling and Therapeutic Response to p38-Targeted Therapy in Colorectal Cancer"],"prefix":"10.1016","volume":"2","author":[{"given":"Yanjie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.F. Steven","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2015.11.031_bb0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrc3944","article-title":"Examining the utility of patient-derived xenograft mouse models","volume":"15","author":"Aparicio","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ebiom.2015.11.031_bb0010","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri1865","article-title":"The many paths to p38 mitogen-activated protein kinase activation in the immune system","volume":"6","author":"Ashwell","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0015","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-10-1099","article-title":"Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin","author":"Bhagwat","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0020","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1158\/1535-7163.MCT-13-0513","article-title":"Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity","volume":"13","author":"Campbell","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.cdd.4402076","article-title":"A novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells","volume":"14","author":"Comes","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0030","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/onc.2011.321","article-title":"P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance","volume":"31","author":"de la Cruz-Morcillo","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2015.11.031_bb0035","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.2014.59.7633","article-title":"Metastatic colorectal cancer: current state and future directions","volume":"33","author":"Fakih","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0040","first-page":"153","article-title":"Colorectal carcinoma: pathologic aspects","volume":"3","author":"Fleming","year":"2012","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0045","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ccr.2014.02.019","article-title":"Dual Function of p38\u03b1 MAPK in Colon Cancer: Suppression of Colitis-Associated Tumor Initiation but Requirement for Cancer Cell Survival","volume":"25","author":"Gupta","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2015.11.031_bb0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tibs.2007.06.007","article-title":"The Pathways to Tumor Suppression via Route p38","volume":"32","author":"Han","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1\u2013TSC2 Complex: A Molecular Switchboard Controlling Cell Growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0060","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is Phosphorylated and Inhibited by Akt and Suppresses mTOR Signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/bj3530417","article-title":"Protein Phosphatase 2A: A Highly Regulated Family of Serine\/Threonine Phosphatases Implicated in Cell Growth and Signalling","volume":"353","author":"Janssens","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0070","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/1947601913507951","article-title":"Role of p38 MAP Kinase Signal Transduction in Solid Tumors","volume":"4","author":"Koul","year":"2013","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ebiom.2015.11.031_bb0075","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrd1177","article-title":"p38 MAP Kinases: Key Signalling Molecules as Therapeutic Targets for Inflammatory Diseases","volume":"2","author":"Kumar","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0080","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1128\/MCB.01369-06","article-title":"The 14\u20133-3\u03c4 Phosphoserine-Binding Protein Is Required for Cardiomyocyte Survival","volume":"27","author":"Lau","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0085","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/372739a0","article-title":"A Protein Kinase Involved in the Regulation of Inflammatory Cytokine Biosynthesis","volume":"372","author":"Lee","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2015.11.031_bb0090","doi-asserted-by":"crossref","first-page":"13663","DOI":"10.1074\/jbc.M300862200","article-title":"The p38 and MK2 Kinase Cascade Phosphorylates Tuberin, the Tuberous Sclerosis 2 Gene Product, and Enhances its Interaction with 14\u20133-3","volume":"278","author":"Li","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0095","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of Pancreatic Cancer Stem Cells","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0100","volume":"vol. 286","author":"Liu","year":"2004"},{"key":"10.1016\/j.ebiom.2015.11.031_bb0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","article-title":"Phosphorylation and Functional Inactivation of TSC2 by Erk Implications for Tuberous Sclerosis and Cancer Pathogenesis","volume":"121","author":"Ma","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2015.11.031_bb0110","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11156","article-title":"Emergence of KRAS Mutations and Acquired Resistance to Anti-EGFR Therapy in Colorectal Cancer","volume":"486","author":"Misale","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2015.11.031_bb0115","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-14-0462","article-title":"Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution","author":"Misale","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nprot.2007.25","article-title":"Establishment of Human Tumor Xenografts in Immunodeficient Mice","volume":"2","author":"Morton","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0968-0004(00)01595-4","article-title":"p38 MAP Kinases: Beyond the Stress Response","volume":"25","author":"Nebreda","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0130","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(14)60417-7","article-title":"Losmapimod, a Novel p38 Mitogen-Activated Protein Kinase Inhibitor, in non-ST-Segment Elevation Myocardial Infarction: A Randomised Phase 2 Trial","volume":"384","author":"Newby","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2015.11.031_bb0135","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1158\/0008-5472.CAN-10-2726","article-title":"Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma","volume":"71","author":"Paillas","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0140","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ncb840","article-title":"Akt Regulates Growth by Directly Phosphorylating Tsc2","volume":"4","author":"Potter","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0145","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1016\/S0960-894X(03)00656-5","article-title":"The Kinetics of Binding to p38MAP Kinase by Analogues of BIRB 796","volume":"13","author":"Regan","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.med.60.041807.132435","article-title":"Evolving Treatment of Advanced Colon Cancer","volume":"60","author":"Segal","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0155","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-05-0068","article-title":"Mammalian Target of Rapamycin Inhibitors Activate the AKT Kinase in Multiple Myeloma Cells by up-Regulating the Insulin-Like Growth Factor Receptor\/Insulin Receptor Substrate-1\/Phosphatidylinositol 3-Kinase Cascade","volume":"4","author":"Shi","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0160","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1158\/0008-5472.CAN-05-0917","article-title":"Activation of Akt and eIF4E Survival Pathways by Rapamycin-Mediated Mammalian Target of Rapamycin Inhibition","volume":"65","author":"Sun","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0165","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1074\/jbc.M112.425553","article-title":"LY2228820 Dimesylate, a Selective Inhibitor of p38 Mitogen-Activated Protein Kinase, Reduces Angiogenic Endothelial Cord Formation in Vitro and in Vivo","volume":"288","author":"Tate","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0170","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","article-title":"Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex Toward Rheb","volume":"13","author":"Tee","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0175","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ccell.2014.09.008","article-title":"Rab1A Is an mTORC1 Activator and a Colorectal Oncogene","volume":"26","author":"Thomas","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2015.11.031_bb0180","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal Integration by JNK and p38 MAPK Pathways in Cancer Development","volume":"9","author":"Wagner","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ebiom.2015.11.031_bb0185","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.celrep.2015.03.040","article-title":"Identification of a Non-Gatekeeper Hot Spot for Drug-Resistant Mutations in mTOR Kinase","volume":"11","author":"Wu","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0190","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4161\/cc.11.3.19096","article-title":"mTOR-Independent 4E-BP1 Phosphorylation is Associated with Cancer Resistance to mTOR Kinase Inhibitors","volume":"11","author":"Zhang","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ebiom.2015.11.031_bb0195","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 Activates mTOR and Disrupts PI3K-Akt Signaling Through Downregulation of PDGFR","volume":"112","author":"Zhang","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ebiom.2015.11.031_bb0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc2559","article-title":"Targeting Cancer with Small Molecule Kinase Inhibitors","volume":"9","author":"Zhang","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ebiom.2015.11.031_bb0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.drudis.2011.02.008","article-title":"Targeting the mTOR Kinase Domain: The Second Generation of mTOR Inhibitors","volume":"16","author":"Zhang","year":"2011","journal-title":"Drug Discov. Today"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396415302152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396415302152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T17:51:01Z","timestamp":1567360261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396415302152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S2352396415302152"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2015.11.031","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PP2AC Level Determines Differential Programming of p38-TSC-mTOR Signaling and Therapeutic Response to p38-Targeted Therapy in Colorectal Cancer","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2015.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}